Eli Lilly and Company - Net Receivables

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Net-Receivables" stands at 19.46 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.

As of the end of Eli Lilly and Company's third quarter, the item "Net Receivables" stands at 19.46 Billion USD. This represents an increase of 13.09 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 61.45 percent compared to the value the year prior.
The 1 year change in percent is 61.45.
The 3 year change in percent is 133.73.
The 5 year change in percent is 232.90.
The 10 year change in percent is 378.33.

The Serie's long term average value is 6.51 Billion United States Dollars. It's latest available value, on 09/30/2025, is 198.83 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2014, to it's latest available value, on 09/30/2025, is +435.33%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.